337 related articles for article (PubMed ID: 11179953)
1. Cloned neuropeptide Y (NPY) Y1 and pancreatic polypeptide Y4 receptors expressed in Chinese hamster ovary cells show considerable agonist-driven internalization, in contrast to the NPY Y2 receptor.
Parker SL; Kane JK; Parker MS; Berglund MM; Lundell IA; Li MD
Eur J Biochem; 2001 Feb; 268(4):877-86. PubMed ID: 11179953
[TBL] [Abstract][Full Text] [Related]
2. Agonist internalization by cloned Y1 neuropeptide Y (NPY) receptor in Chinese hamster ovary cells shows strong preference for NPY, endosome-linked entry and fast receptor recycling.
Parker SL; Parker MS; Lundell I; Balasubramaniam A; Buschauer A; Kane JK; Yalcin A; Berglund MM
Regul Pept; 2002 Jul; 107(1-3):49-62. PubMed ID: 12137966
[TBL] [Abstract][Full Text] [Related]
3. Ligand internalization by cloned neuropeptide Y Y5 receptors excludes Y2 and Y4 receptor-selective peptides.
Parker SL; Parker MS; Buschauer A; Balasubramaniam A
Eur J Pharmacol; 2003 Aug; 474(1):31-42. PubMed ID: 12909193
[TBL] [Abstract][Full Text] [Related]
4. BODIPY-conjugated neuropeptide Y ligands: new fluorescent tools to tag Y1, Y2, Y4 and Y5 receptor subtypes.
Dumont Y; Gaudreau P; Mazzuferi M; Langlois D; Chabot JG; Fournier A; Simonato M; Quirion R
Br J Pharmacol; 2005 Dec; 146(8):1069-81. PubMed ID: 16231000
[TBL] [Abstract][Full Text] [Related]
5. Internalization of pancreatic polypeptide Y4 receptors: correlation of receptor intake and affinity.
Parker MS; Lundell I; Parker SL
Eur J Pharmacol; 2002 Oct; 452(3):279-87. PubMed ID: 12359268
[TBL] [Abstract][Full Text] [Related]
6. Internalization of neuropeptide Y Y1 and Y5 and of pancreatic polypeptide Y4 receptors is inhibited by lithium in preference to sodium and potassium ions.
Parker MS; Parker SL; Kane JK
Regul Pept; 2004 Apr; 118(1-2):67-74. PubMed ID: 14759559
[TBL] [Abstract][Full Text] [Related]
7. Blockade of pancreatic polypeptide-sensitive neuropeptide Y (NPY) receptors by agonist peptides is prevented by modulators of sodium transport. Implications for receptor signaling and regulation.
Parker MS; Berglund MM; Lundell I; Parker SL
Peptides; 2001 Jun; 22(6):887-98. PubMed ID: 11390018
[TBL] [Abstract][Full Text] [Related]
8. Ligand association with the rabbit kidney and brain Y1, Y2 and Y5-like neuropeptide Y (NPY) receptors shows large subtype-related differences in sensitivity to chaotropic and alkylating agents.
Parker SL; Parker MS
Regul Pept; 2000 Feb; 87(1-3):59-72. PubMed ID: 10710289
[TBL] [Abstract][Full Text] [Related]
9. Internalization of cloned pancreatic polypeptide receptors is accelerated by all types of Y4 agonists.
Parker MS; Sah R; Sheriff S; Balasubramaniam A; Parker SL
Regul Pept; 2005 Dec; 132(1-3):91-101. PubMed ID: 16213038
[TBL] [Abstract][Full Text] [Related]
10. Binding of chimeric NPY/galanin peptides M32 and M242 to cloned neuropeptide Y receptor subtypes Y1, Y2, Y4, and Y5.
Berglund MM; Saar K; Lundell I; Langel U; Larhammar D
Neuropeptides; 2001; 35(3-4):148-53. PubMed ID: 11884204
[TBL] [Abstract][Full Text] [Related]
11. Regionally-selective down-regulation of NPY receptor subtypes in the obese Zucker rat. Relationship to the Y5 'feeding' receptor.
Widdowson PS
Brain Res; 1997 May; 758(1-2):17-25. PubMed ID: 9203528
[TBL] [Abstract][Full Text] [Related]
12. GR231118 (1229U91) and other analogues of the C-terminus of neuropeptide Y are potent neuropeptide Y Y1 receptor antagonists and neuropeptide Y Y4 receptor agonists.
Parker EM; Babij CK; Balasubramaniam A; Burrier RE; Guzzi M; Hamud F; Mukhopadhyay G; Rudinski MS; Tao Z; Tice M; Xia L; Mullins DE; Salisbury BG
Eur J Pharmacol; 1998 May; 349(1):97-105. PubMed ID: 9669502
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide Y as a partial agonist of the Y1 receptor.
Sah R; Balasubramaniam A; Parker MS; Sallee F; Parker SL
Eur J Pharmacol; 2005 Nov; 525(1-3):60-8. PubMed ID: 16293244
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of (125)I-1229U91 binding to Y1 and Y4 neuropeptide Y/Peptide YY receptors.
Schober DA; Gackenheimer SL; Heiman ML; Gehlert DR
J Pharmacol Exp Ther; 2000 Apr; 293(1):275-80. PubMed ID: 10734179
[TBL] [Abstract][Full Text] [Related]
15. The neuropeptide Y Y1 antagonist, 1229U91, a potent agonist for the human pancreatic polypeptide-preferring (NPY Y4) receptor.
Schober DA; Van Abbema AM; Smiley DL; Bruns RF; Gehlert DR
Peptides; 1998; 19(3):537-42. PubMed ID: 9533642
[TBL] [Abstract][Full Text] [Related]
16. Coexpression of Y1, Y2, and Y4 receptors in smooth muscle coupled to distinct signaling pathways.
Misra S; Murthy KS; Zhou H; Grider JR
J Pharmacol Exp Ther; 2004 Dec; 311(3):1154-62. PubMed ID: 15308651
[TBL] [Abstract][Full Text] [Related]
17. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML
Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275
[TBL] [Abstract][Full Text] [Related]
18. Cloning and characterization of rabbit neuropeptide Y receptor subtypes.
Umeda T; Kanatani A; Iwaasa H
Peptides; 2009 Aug; 30(8):1441-7. PubMed ID: 19481128
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of the human neuropeptide Y Y2-receptor.
Ingenhoven N; Eckard CP; Gehlert DR; Beck-Sickinger AG
Biochemistry; 1999 May; 38(21):6897-902. PubMed ID: 10346911
[TBL] [Abstract][Full Text] [Related]
20. Identification and distribution of mRNA encoding the Y1, Y2, Y4, and Y5 receptors for peptides of the PP-fold family in the rat intestine and colon.
Goumain M; Voisin T; Lorinet AM; Laburthe M
Biochem Biophys Res Commun; 1998 Jun; 247(1):52-6. PubMed ID: 9636652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]